期刊文献+

低分子肝素治疗妊娠晚期羊水过少的临床观察 被引量:4

下载PDF
导出
摘要 目的:探讨低分子肝素治疗妊娠晚期羊水过少的临床效果及安全性。方法:将65例妊娠28~37周羊水过少的患者分为两组,治疗组32例,对照组33例。治疗组静脉点滴低分子肝素50mg/d,4~6小时滴完,对照组静脉点滴低分子右旋糖酐500ml+丹参注射液14ml,两组均7天为一个疗程。一疗程后复查羊水指数,并比较两组剖宫产率、产后出血量和新生儿窒息率。结果:治疗组羊水指数增加明显高于对照组(P<0.05),新生儿窒息率低于对照组(P<0.05),剖宫产率、产后出血量两组无显著差异。随访半年,新生儿体能、智能全部正常,孕母无任何并发症。结论:低分子肝素治疗妊娠晚期羊水过少是安全、有效的方法,可以显著增加羊水指数,改善妊娠结局。
出处 《北方药学》 2013年第2期46-47,共2页 Journal of North Pharmacy
  • 相关文献

参考文献4

二级参考文献26

  • 1褚红女.肝素治疗未足月妊娠羊水过少的疗效评价[J].中华医学杂志,2004,84(9):745-746. 被引量:42
  • 2中华医学杂志编委会.肝素临床应用专题座谈会纪要[J].中华医学杂志,1987,67(6):304-304.
  • 3Many A,Koren G.Low-molecular-weight heparins during pregnancy[J].Can Fam Physician,2005,51:199-201.
  • 4Kujovich JL.Thrombophilia and pregnancy complications[J].Am J Obstet Gynecol,2004,191 (2):412-424.
  • 5Spaanderman ME,Aardenburg R,Ekhart TH,et al.Pre-pregnant prediction of recurrent preeclampsia in normotensive thrombophilic formerly preeclamptic women receiving prophylactic antithrombotic medication[J].J Soc Gynecol Investig,2005,12(2):112-117.
  • 6Dulitzki M,Pauzner R,Langevitz P,et al.Low-molecular-weight heparin during pregnancy and delivery:preliminary experience with 41 pregnancies[J].Obstet Gynecol,1996,87 (3):380-383.
  • 7Schneider D,Heilmann L,Harenberg J.Placental transfer of low-molecular weight heparin[J].Geburtshilfe Frauenheilkd,1995,55(2):93-98.
  • 8Riyazi N,Leeda M,de Vries JI,et al.Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction:a preliminary study[J].Eur J Obstet Gynecol Reprod Biol,1998,80(1):49-54.
  • 9Nelson PC.Heparin-induced osteoporosis[J].Scand J Rheumatol Suppl,1998,107:68-71.
  • 10di Somone N,Meroni PL,de Papa N,et al.Antiphopholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I[J].Arthritis Rheum,2000,43 (1):140-150.

共引文献45

同被引文献29

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部